Application of cytokines in the treatment of breast cancer

Abstract

Breast cancer is one of the most common cancers in women globally. Breast cancer is still a major public health issue despite great advancements in diagnosis and treatment. In 2020, there will be about 2.3 million new cases of breast cancer, including about 600,000 deaths. In China, breast cancer is the most common cancer among women aged 15-44, and its mortality rate is on the rise. In recent years, researchers have focused on using cytokines as a potential therapy for breast cancer. Small proteins known as cytokines are essential in the immune system's response to cancer cells. This article discusses the current state of research on using cytokines to treat breast cancer. Specifically, it explores four methods of cytokine therapy: interferon therapy, tumor necrosis factor therapy, interleukin therapy, and colony-stimulating factor therapy. The article also examines the experimental evidence supporting the use of these therapies in treating breast cancer. Overall, this research suggests that cytokine therapy may hold promise as a new approach to treating breast cancer.